Genus Capital Management’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-46,469
Closed -$3.64M 332
2024
Q4
$3.64M Buy
46,469
+30,238
+186% +$2.51M 0.49% 70
2024
Q3
$1.31M Sell
16,231
-38,243
-70% -$3.16M 0.17% 118
2024
Q2
$4.56M Buy
+54,474
New +$4.44M 0.6% 59
2024
Q1
Sell
-6,925
Closed -$559K 358
2023
Q4
$559K Buy
+6,925
New +$480K 0.08% 143

Other funds holding STN

Genus Capital Management's STN Position: Q2 2026 in Review

Genus Capital Management sold out of Stantec (STN) in Q2 2026, closing a stake of 3,075 shares — an estimated $265K sold.

Genus Capital Management first reported a position in STN in Q2 2023 and held it in 8 quarters. The position peaked at $7M in Q2 2025. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Genus Capital Management reported no remaining Stantec position as of Q2 2026 after selling out during the quarter.
  • Genus Capital Management sold 3,075 Stantec shares in Q2 2026, an estimated $265K.
  • Genus Capital Management first reported a position in Stantec in Q2 2023 and held it in 8 quarters.
  • Genus Capital Management's Stantec position peaked at $7M in Q2 2025.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.